Daniella Kukin
Acute Care · Brooklyn, NYNPI 1619652609
Payments from drug & device makers
Across 46 payments — averaging $22.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$331
- Ardelyx, Inc.$191
- Aimmune Therapeutics, Inc.$109
- Novartis$83
- Lilly USA, LLC$82
- Merck$57
- plus $205 from 8 others
What the payments were for
- Food & beverage$1,057100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $331 |
| Ardelyx, Inc. | 8 | $191 |
| Aimmune Therapeutics, Inc. | 2 | $109 |
| Novartis | 3 | $83 |
| Lilly USA, LLC | 4 | $82 |
| Merck | 3 | $57 |
| AstraZeneca | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Novo Nordisk | 1 | $27 |
| Exact Sciences | 1 | $24 |
| GSK | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Shield Therapeutics Inc | 1 | $20 |
| Pfizer | 1 | $15 |
How this compares
$1,057 in reported general payments places this provider in the 80th percentile of 980 acute care providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 23 | $3,599 |
| Naproxen Sodium | 12 | $1,199 |
| Diclofenac Sodium ErDiclofenac Sodium | 14 | $1,169 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $667 |
| Rosuvastatin Calcium | 21 | $196 |
| Metoprolol Succinate | 30 | $184 |
| Omeprazole | 36 | $150 |
| Atorvastatin Calcium | 34 | $130 |
| Famotidine | 18 | $126 |
| Pantoprazole Sodium | 13 | $126 |
| Amlodipine Besylate | 31 | $98 |
| Losartan Potassium | 25 | $93 |
| Metformin Hcl | 20 | $64 |
| Fluticasone Propionate | 15 | $61 |
| Tamsulosin Hcl | 12 | $43 |
Paid to pharmacies, not to this prescriber.
Other acute care in Brooklyn
- Ann HarrisBrooklyn$14K
- Sun Young GeninBrooklyn$4K
- Daniel VerinaNew York$464K
- Michele BiscossiSaratoga Springs$64K
- Heidi YipCanandaigua$29K
- Katie WorthingtonNew York$25K
- Loveth AdenugaNew York$20K
- Katherine DukeNew York$18K
- Marcel RozarioMedina$10K
- Julie Anne RoldanNew York$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.